Sikiri P, Seiwerth S, Grabarevi Z, Rucman R, Petek M, Jagi V, Turkovi B, Rotkvi I, Mise S, Zorici I, Gjurasin M, Konjevoda P, Separovi J, Ljubanovi D, Artukovi B, Bratuli M, Tisljar M, Jurina L, Buljat G, Mikli P, Marovi A
PMID 16042604
FM affects about 15% of the world population
Longevity medicine increasingly turns to targeted therapies like ipamorelin to support patients experiencing reduced muscle tone, fatigue, and poor sleep
What community members commonly report: Sustained energy improvements that persist after stopping injections Improved exercise tolerance and recovery Some report improved skin elasticity and reduced fine lines (subjective) Occasional reports of improved bloodwork markers (inflammatory markers, kidney function) Joint comfort improvements, particularly in those with pre-existing stiffness What to monitor: This is an appropriate time for follow-up bloodwork